Tissue selectivity of insulin detemir action in vivo

Diabetologia

Volumn 49, Issue 6, 2006, Pages 1274-1282

  Hennige, A M ^a   Sartorius, T ^a   Tschritter, O ^a   Preissl, H ^a   Fritsche, A ^a   Ruth, P ^a   Haring H U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Brain; Cerebral cortex; Electroencephalography; Hypothalamus; Insulin analogues; Insulin detemir; Insulin receptor signalling

Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN DETEMIR; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG SELECTIVITY; ELECTROENCEPHALOGRAM; HYPOTHALAMUS; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; RECOMBINANT DNA TECHNOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BRAIN; ELECTROENCEPHALOGRAPHY; INSULIN; KINETICS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 33646530498     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0192-9     Document Type: Article

References (33)

1. Mudaliar SR, Lindberg FA, Joyce M et al (1999) Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 22:1501-1506
2. Gerich JE (2002) Novel insulins: expanding options in diabetes management. Am J Med 113:308-316
3. Gerich JE (2004) Insulin glargine: long-acting basal insulin analog for improved metabolic control. Curr Med Res Opin 20:31-37
4. Havelund S, Plum A, Ribel U et al (2004) The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin. Pharm Res 21:1498-1504
5. Kurtzhals P, Havelund S, Jonassen I, Markussen J (1997) Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue. J Pharm Sci 86:1365-1368
6. Kurtzhals P (2004) Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir. Int J Obes Relat Metab Disord 28(Suppl 2):S23-S28
7. Kurtzhals P, Schaffer L, Sorensen A et al (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999-1005
8. Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Ribel U, Markussen J (1996) Albumin binding and time action of acylated insulins in various species. J Pharm Sci 85:304-308
9. De Leeuw I, Vague P, Selam JL et al (2005) Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab 7:73-82
10. Heise T, Nosek L, Ronn BB et al (2004) Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 53:1614-1620
11. Vague P, Selam JL, Skeie S et al (2003) Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care 26:590-596
12. Wing RR, Klein R, Moss SE (1990) Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes. Diabetes Care 13:1106-1109
13. Bailey CJ, Grant PJ (1998) The UK Prospective Diabetes Study. Lancet 352:1932
14. Fritsche A, Haring H (2004) At last, a weight neutral insulin? Int J Obes Relat Metab Disord 28(Suppl 2):S41-S46
15. White MF (2002) IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:E413-E422
16. Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170-184
17. Lin X, Taguchi A, Park S et al (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 114:908-916
18. Porte D Jr, Baskin DG, Schwartz MW (2005) Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264-1276
19. Hennige AM, Burks DJ, Ozcan U et al (2003) Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112:1521-1532
20. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Haring HU (1997) Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK- 2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40:1358-1362
21. Levy WJ (1987) Effect of epoch length on power spectrum analysis of the EEG. Anesthesiology 66:489-495
22. Woods SC, Seeley RJ, Baskin DG, Schwartz MW (2003) Insulin and the blood-brain barrier. Curr Pharm Des 9:795-800
23. Knott GW, Dziegielewska KM, Habgood MD, Li ZS, Saunders NR (1997) Albumin transfer across the choroid plexus of South American opossum (Monodelphis domestica). J Physiol 499:179-194
24. Shen DD, Artru AA, Adkison KK (2004) Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Adv Drug Deliv Rev 56:1825-1857
25. Benedict C, Hallschmid M, Hatke A et al (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29:1326-1334
26. Hordern SV, Wright JE, Umpleby AM, Shojaee-Moradie F, Amiss J, Russell-Jones DL (2005) Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp. Diabetologia 48:420-426
27. Burks DJ, de Mora JF, Schubert M et al (2000) IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 407:377-382
28. Bruning JC, Gautam D, Burks DJ et al (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125
29. Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21:63-74
30. Schubert M, Brazil DP, Burks DJ et al (2003) Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084-7092
31. Niswender KD, Morrison CD, Clegg DJ et al (2003) Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52:227-231
32. Selbach O, Doreulee N, Bohla C et al (2004) Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 127:519-528
33. Molle M, Marshall L, Gais S, Born J (2004) Learning increases human electroencephalographic coherence during subsequent slow sleep oscillations. Proc Natl Acad Sci USA 101:13963-13968